KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Receivables: 2014-2025

Historic Receivables for Exact Sciences (EXAS) over the last 11 years, with Sep 2025 value amounting to $337.9 million.

  • Exact Sciences' Receivables rose 7.90% to $337.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 13.83%. This contributed to the annual value of $274.9 million for FY2024, which is 12.04% up from last year.
  • According to the latest figures from Q3 2025, Exact Sciences' Receivables is $337.9 million, which was down 12.48% from $386.0 million recorded in Q2 2025.
  • Over the past 5 years, Exact Sciences' Receivables peaked at $386.0 million during Q2 2025, and registered a low of $158.0 million during Q4 2022.
  • Its 3-year average for Receivables is $280.7 million, with a median of $282.0 million in 2024.
  • Per our database at Business Quant, Exact Sciences' Receivables surged by 82.89% in 2021 and then decreased by 27.05% in 2022.
  • Quarterly analysis of 5 years shows Exact Sciences' Receivables stood at $216.6 million in 2021, then decreased by 27.05% to $158.0 million in 2022, then spiked by 55.23% to $245.3 million in 2023, then grew by 12.04% to $274.9 million in 2024, then grew by 7.90% to $337.9 million in 2025.
  • Its last three reported values are $337.9 million in Q3 2025, $386.0 million for Q2 2025, and $309.7 million during Q1 2025.